Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–17 of 17 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT03892993
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection
NCT07612293
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT00655655
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +70 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT02592356
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
NCT01709435
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +30 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States
Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer
NCT00519896
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +26 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00118248
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01204476
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +52 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01155258
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +115 more
- Locations
-
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT00134043
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +25 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
- Conditions
- Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, +96 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT00068497
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +132 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
NCT02867592
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT07118176
- Conditions
- Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +127 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
NCT04759911
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +25 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- University of Michigan Health Systems Ann Arbor, Michigan, United States
- M D Anderson Cancer Center Houston, Texas, United States
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
NCT02293954
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +59 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States